Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Therapeutic Target for Potential Rheumatic Disease Treatment

11.10.2004


Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”



The chemical pathway involves the body’s responses to potent substances called cytokines which have dramatic influence on the progression, or reversal, of diseases such as rheumatoid arthritis and lupus.

Doctors have long known that cytokines can regulate diseases such as lupus, but it is now becoming appreciated that lupus can also make cytokines fail to work properly. What is not fully understood is just how the cytokines become “switched on” to cause damage. Understanding the molecular chemistry that turns on the switch becomes central to stemming disease.


The HHS in vitro and animal study work focused on the key role of interferon chemicals produced in the body as they impact cytokines production and influence inflammation. One particular kind of interferon (IFN), IFN-alpha, was believed to play a key role in lupus and is a therapeutic target for this disease. The investigators found that inflammation, as it occurs in lupus patients, changed cellular responses to IFN-alpha and made cellular response become more inflammatory and toxic.

This work supports a concept that is emerging from the laboratory of, Lionel B. Ivashkiv, M.D., lead investigator in the study at HSS published Oct 3, 2004 in “Nature Immunology.” The paper is titled “Amplification of IFN-alpha induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors.”

Specifically Dr. Ivashkiv believes that cytokine signaling is reprogrammed in patients with rheumatic diseases. This reprogramming amplifies the toxic aspects of cytokines, while compromising the effectiveness of “good cytokines” that patients produce in their bodies in an attempt to heal themselves. “We found that if we inject these IFNs in a normal mouse, there was no effect but if we injected the IFN-alpha in a mouse with lupus, we saw evidence of an influx of cells and the start of inflammation at the site where it was injected,” said Dr. Ivashkiv.

“People with rheumatic diseases like lupus and arthritis have cytokine response problems that prevent these chemicals from working properly and doing what they are supposed to do to heal the body. If we can identify and influence the chemicals that result in this and prevent it from happening, we can prevent the cycle of inflammatory response that damages these patients instead of helping them,” said Dr. Ivashkiv.

In lupus, the immune system attacks the body’s own cells and tissue, especially the skin, joints, blood, heart, lungs and kidneys. It affects 1-1.5 million Americans and is a leading cause of kidney disease, stroke and cardiovascular disease in young women.

| newswise
Further information:
http://www.hss.edu
http://www.nature.com

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>